Evidence map›Paper›PMID 33584725›Full record

SynthesisFrontiers in immunology2020

The Role of PTX3 in Mineralization Processes and Aging-Related Bone Diseases.

Umberto Tarantino, Chiara Greggi, Ida Cariati, Virginia Veronica Visconti, Monica Gasparini, Marco Cateni, Elena Gasbarra, Annalisa Botta, Antonietta Salustri, Manuel Scimeca

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. [Knockdown ofBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Umberto TarantinoDepartment of Clinical Science and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Chiara GreggiDepartment of Orthopedics and Traumatology, Policlinico Tor Vergata (PTV) Foundation, Rome, Italy.
Ida CariatiDepartment of Orthopedics and Traumatology, Policlinico Tor Vergata (PTV) Foundation, Rome, Italy.
Virginia Veronica ViscontiDepartment of Orthopedics and Traumatology, Policlinico Tor Vergata (PTV) Foundation, Rome, Italy.
Monica GaspariniDepartment of Clinical Science and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Marco CateniDepartment of Clinical Science and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Elena GasbarraDepartment of Clinical Science and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Annalisa BottaDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
Antonietta SalustriDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
Manuel ScimecaDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
University of Rome Tor Vergata · ITPoliclinico Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Long Pentraxin 3 (PTX3) is a multifunctional glycoprotein released by peripheral blood leukocytes and myeloid dendritic cells in response to primary pro-inflammatory stimuli, that acts as a non-redundant component of the humoral arm of innate immunity. In addition to the primary role in the acute inflammatory response, PTX3 seems to be involved in other physiological and pathological processes. Indeed, PTX3 seems to play a pivotal role in the deposition and remodeling of bone matrix during the mineralization process, promoting osteoblasts differentiation and activity. Recently, PTX3 was seen to be involved in the ectopic calcifications' formation in breast cancer disease. In this regard, it has been observed that breast cancer tumors characterized by high expression of PTX3 and high amount of Breast Osteoblast Like Cells (BOLCs) showed several Hydroxyapatite (HA) microcalcifications, suggesting a likely role for PTX3 in differentiation and osteoblastic activity in both bone and extra-bone sites. Furthermore, given its involvement in bone metabolism, several studies agree with the definition of PTX3 as a molecule significantly involved in the pathogenesis of age-related bone diseases, such as osteoporosis, both in mice and humans. Recent results suggest that genetic and epigenetic mechanisms acting on

Indexed as

AgingAnimalsCalcification, PhysiologicC-Reactive ProteinHumansMiceNerve Tissue ProteinsOsteoporosisPentraxinsSerum Amyloid P-ComponentC-Reactive ProteinNerve Tissue ProteinsPentraxinsSerum Amyloid P-Componentagingbone diseasesectopic calcificationfracture healinginflammationmineralizationosteoporosisPTX3

Identifiers

PMID33584725
PMCPMC7878364
OpenAlexW3128249383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.